Literature DB >> 7775597

P-glycoprotein stability is affected by serum deprivation and high cell density in multidrug-resistant cells.

C Muller1, G Laurent, V Ling.   

Abstract

The control of P-glycoprotein (Pgp) expression in multidrug-resistant cells (MDR) is complex and may be regulated at different levels. We have investigated Pgp stability in four different human and hamster MDR cell lines. Using a pulse-chase procedure we show that Pgp half-life is between 14 and 17 h in all these cell lines when they are growing exponentially. However, in the presence of a low level of serum, Pgp half-life is increased four to sixfold. A similar effect is observed when the cell cultures are maintained in high cell density. The increased Pgp stability appears to be differently regulated as serum deprivation results in a general enhanced degradation of total cytoplasmic and membrane proteins. Moreover, the observed serum effect suggests the involvement of growth factors in the control of Pgp stability. These findings suggest that protein stability may be an important factor in the regulation of Pgp expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775597     DOI: 10.1002/jcp.1041630314

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  18 in total

1.  The multidrug resistance pump ABCB1 is a substrate for the ubiquitin ligase NEDD4-1.

Authors:  Begum G Akkaya; Joseph K Zolnerciks; Tasha K Ritchie; Bjoern Bauer; Anika M S Hartz; James A Sullivan; Kenneth J Linton
Journal:  Mol Membr Biol       Date:  2015-05-26       Impact factor: 2.857

2.  Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells.

Authors:  Xiao-Ping Chen; Qi Wang; Jian Guan; Zhi-Yong Huang; Wan-Guang Zhang; Bi-Xiang Zhang
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

3.  P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia.

Authors:  Gwen McCaffrey; William D Staatz; Lucy Sanchez-Covarrubias; Jessica D Finch; Kristen Demarco; Mei-Li Laracuente; Patrick T Ronaldson; Thomas P Davis
Journal:  J Neurochem       Date:  2012-07-10       Impact factor: 5.372

4.  Knocking down breast cancer resistance protein (Bcrp) by adenoviral vector-mediated RNA interference (RNAi) in sandwich-cultured rat hepatocytes: a novel tool to assess the contribution of Bcrp to drug biliary excretion.

Authors:  Wei Yue; Koji Abe; Kim L R Brouwer
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

5.  Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cells.

Authors:  Wei Jin; Kathleen W Scotto; William N Hait; Jin-Ming Yang
Journal:  Biochem Pharmacol       Date:  2007-06-17       Impact factor: 5.858

Review 6.  Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?

Authors:  Richard Callaghan; Frederick Luk; Mary Bebawy
Journal:  Drug Metab Dispos       Date:  2014-02-03       Impact factor: 3.922

7.  FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin.

Authors:  David E Joyner; Sylvia H Trang; Albert J Aboulafia; Timothy A Damron; R L Randall; R Lor Randall
Journal:  Fam Cancer       Date:  2009       Impact factor: 2.375

8.  Identification of the efflux transporter of the fluoroquinolone antibiotic ciprofloxacin in murine macrophages: studies with ciprofloxacin-resistant cells.

Authors:  Béatrice Marquez; Nancy E Caceres; Marie-Paule Mingeot-Leclercq; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

9.  Psorospermin structural requirements for P-glycoprotein resistance reversal.

Authors:  Steven S Carey; Mary Gleason-Guzman; Vijay Gokhale; Laurence H Hurley
Journal:  Mol Cancer Ther       Date:  2008-11       Impact factor: 6.261

10.  Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway.

Authors:  Anika M S Hartz; Yu Zhong; Andrea Wolf; Harry LeVine; David S Miller; Björn Bauer
Journal:  J Neurosci       Date:  2016-02-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.